预填充式注射器市场规模、份额、成长分析（按类型、材料、应用、分销管道和地区）－2025 年至 2032 年产业预测

2023 年预填充式注射器市场规模价值 83 亿美元，预计将从 2024 年的 92.4 亿美元成长到 2032 年的 217.5 亿美元，预测期内（2025-2032 年）的复合年增长率为 11.3%。

预填充式注射器正迅速成为一种流行的单剂量药物输送方法，製药业正在寻求一种便捷的解决方案。世界卫生组织 (WHO) 2022 年的一项研究强调，避孕等有效的自我护理干预措施可以显着减少意​​外怀孕，凸显了医疗保健领域自我管理的趋势日益增长。由于每年人们花在自我护理上的时间超过 8,700 小时，但花在就诊上的时间却不到一小时，因此对预填充式注射器的需求预计会飙升。此外，糖尿病和关节炎患者数量的增加以及已开发国家生物相似药的日益普及将进一步推动市场成长。特别是据报道美国每年有超过1400万人患有关节炎，预填充式注射器被定位为患者自我护理和安全的重要技术创新。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管分析
• 原料分析

预填充式注射器市场规模（按类型及复合年增长率） (2025-2032)

• 市场概览
• 一次性的
• 可重复使用的

预填充式注射器市场规模（按材料和复合年增长率） (2025-2032)

• 市场概览
• 玻璃
• 塑胶

预填充式注射器市场规模（依应用划分）及复合年增长率（2025-2032）

• 市场概览
• 疫苗和接种
• 过敏反应
• 类风湿性关节炎
• 糖尿病
• 自体免疫疾病
• 肿瘤学
• 其他的

预填充式注射器市场规模（依通路划分）及复合年增长率（2025-2032）

• 市场概览
• 医院
• 通讯药房
• 门诊手术中心

预填充式注射器市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Becton, Dickinson and Company（BD）（USA）
• Gerresheimer AG（Germany）
• Schott AG（Germany）
• Baxter International Inc.（USA）
• Cardinal Health, Inc.（USA）
• Terumo Corporation（Japan）
• West Pharmaceutical Services, Inc.（USA）
• Nipro Corporation（Japan）
• Ompi（Italy）
• SGD Pharma（France）
• Stevanato Group（Italy）
• Medtronic plc（Ireland）
• Fresenius Kabi AG（Germany）
• Ypsomed Holding AG（Switzerland）
• ARaymondlife SAS（France）
• Credence MedSystems, Inc.（USA）
• Nemera（France）
• Taisei Kako Co., Ltd.（Japan）
• Weigao Group（China）
• Braun Melsungen AG（Germany）

结论和建议

Prefilled Syringes Market size was valued at USD 8.3 billion in 2023 and is poised to grow from USD 9.24 billion in 2024 to USD 21.75 billion by 2032, growing at a CAGR of 11.3% during the forecast period (2025-2032).

Pre-filled syringes are rapidly becoming a preferred delivery method for single-dose medications, driven by the pharmaceutical industry's quest for convenient solutions. The World Health Organization's 2022 findings highlight that effective self-care interventions, such as contraceptives, can significantly lower unintended pregnancies, emphasizing the growing trend towards self-management in healthcare. With individuals dedicating over 8,700 hours annually to self-care but less than an hour in consultations, the demand for pre-filled syringes is projected to surge. Additionally, rising cases of diabetes, arthritis, and the growing presence of biosimilars in developed nations further bolster market growth. Notably, a report indicated arthritis affects over 14 million annually in the U.S., positioning pre-filled syringes as a critical innovation in patient self-care and safety.

Top-down and bottom-up approaches were used to estimate and validate the size of the Prefilled Syringes market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Prefilled Syringes Market Segments Analysis

Global Prefilled Syringes Market is segmented by Type, Material, Application, Distribution Channel and region. Based on Type, the market is segmented into Disposable and Reusable. Based on Material, the market is segmented into Glass and Plastic. Based on Application, the market is segmented into Vaccines and immunizations, Anaphylaxis, Rheumatoid Arthritis, Diabetes, Autoimmune diseases, Oncology and Others. Based on Distribution Channel, the market is segmented into Hospitals, Mail Order Pharmacies and Ambulatory Surgery Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Prefilled Syringes Market

The rising prevalence of chronic conditions, including diabetes mellitus and rheumatoid arthritis, has significantly boosted the demand for vaccines, which are primarily delivered through injections. This surge in vaccine administration has consequently heightened the need for prefilled syringes. These syringes offer controlled packaging that not only decreases the risk of contamination but also helps to minimize dosing errors, positioning them as the ideal option for both vaccines and therapeutics. Their strong application across various medical fields is driving growth in the prefilled syringes market, making them essential in addressing the increasing healthcare challenges associated with chronic illnesses.

Restraints in the Prefilled Syringes Market

The pre-filled syringes market faces several restraints primarily due to the stringent manufacturing processes involved. Unlike conventional syringes, pre-filled syringes require rigorous quality assurance protocols and strict compliance with regulatory standards to guarantee sterility, dosage accuracy, and overall patient safety. Furthermore, manufacturers are obligated to adhere to varying regulatory guidelines across different geographical regions, which can result in extended approval timelines and elevated production costs. These factors collectively pose significant challenges for companies in the pre-filled syringes market, potentially hindering their ability to efficiently produce and distribute these specialized medical devices.

Market Trends of the Prefilled Syringes Market

The prefilled syringes market is witnessing a notable shift towards polymer-based solutions, driven by the demand for enhanced safety and durability in drug delivery systems. Traditionally dominated by glass due to its inert properties, the market is increasingly adopting polymeric materials like cyclic olefin polymers (COP) and cyclic olefin copolymers (COCs). These innovative alternatives mitigate risks associated with glass breakage and contamination, making them particularly suitable for biologics and complex pharmaceuticals that require precise dosing. As pharmaceutical companies prioritize robust and user-friendly designs, the trend towards polymer-based prefilled syringes is anticipated to gain momentum, shaping the future landscape of drug administration.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Raw Material Analysis

Global Prefilled Syringes Market Size by Type & CAGR (2025-2032)

• Market Overview
• Disposable
• Reusable

Global Prefilled Syringes Market Size by Material & CAGR (2025-2032)

• Market Overview
• Glass
• Plastic

Global Prefilled Syringes Market Size by Application & CAGR (2025-2032)

• Market Overview
• Vaccines and immunizations
• Anaphylaxis
• Rheumatoid Arthritis
• Diabetes
• Autoimmune diseases
• Oncology
• Others

Global Prefilled Syringes Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospitals
• Mail Order Pharmacies
• Ambulatory Surgery Centers

Global Prefilled Syringes Market Size & CAGR (2025-2032)

• North America (Type, Material, Application, Distribution Channel)
  • US
  • Canada
• Europe (Type, Material, Application, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Material, Application, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Material, Application, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Material, Application, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gerresheimer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schott AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• West Pharmaceutical Services, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ompi (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGD Pharma (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stevanato Group (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARaymondlife SAS (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Credence MedSystems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nemera (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Taisei Kako Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Weigao Group (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations